Global Intravenous Immunoglobulin(IVIg) Therapy Production, Demand and Key Producers, 2022-2028
This report studies the global Intravenous Immunoglobulin(IVIg) Therapy production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Intravenous Immunoglobulin(IVIg) Therapy, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Intravenous Immunoglobulin(IVIg) Therapy that contribute to its increasing demand across many markets.
The global Intravenous Immunoglobulin(IVIg) Therapy market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Intravenous Immunoglobulin(IVIg) Therapy total production and demand, 2017-2028, (K Units)
Global Intravenous Immunoglobulin(IVIg) Therapy total production value, 2017-2028, (USD Million)
Global Intravenous Immunoglobulin(IVIg) Therapy production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Intravenous Immunoglobulin(IVIg) Therapy consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Intravenous Immunoglobulin(IVIg) Therapy domestic production, consumption, key domestic manufacturers and share
Global Intravenous Immunoglobulin(IVIg) Therapy production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Intravenous Immunoglobulin(IVIg) Therapy production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Intravenous Immunoglobulin(IVIg) Therapy production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Intravenous Immunoglobulin(IVIg) Therapy market based on the following parameters – headquarters, production locations, products portfolio, Intravenous Immunoglobulin(IVIg) Therapy revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Intravenous Immunoglobulin(IVIg) Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Intravenous Immunoglobulin(IVIg) Therapy Market, By Region:
1. How big is the global Intravenous Immunoglobulin(IVIg) Therapy market?
2. What is the demand of the global Intravenous Immunoglobulin(IVIg) Therapy market?
3. What is the year over year growth of the global Intravenous Immunoglobulin(IVIg) Therapy market?
4. What is the production and production value of the global Intravenous Immunoglobulin(IVIg) Therapy market?
5. Who are the key producers in the global Intravenous Immunoglobulin(IVIg) Therapy market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Intravenous Immunoglobulin(IVIg) Therapy, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Intravenous Immunoglobulin(IVIg) Therapy that contribute to its increasing demand across many markets.
The global Intravenous Immunoglobulin(IVIg) Therapy market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Intravenous Immunoglobulin(IVIg) Therapy total production and demand, 2017-2028, (K Units)
Global Intravenous Immunoglobulin(IVIg) Therapy total production value, 2017-2028, (USD Million)
Global Intravenous Immunoglobulin(IVIg) Therapy production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Intravenous Immunoglobulin(IVIg) Therapy consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Intravenous Immunoglobulin(IVIg) Therapy domestic production, consumption, key domestic manufacturers and share
Global Intravenous Immunoglobulin(IVIg) Therapy production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Intravenous Immunoglobulin(IVIg) Therapy production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Intravenous Immunoglobulin(IVIg) Therapy production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Intravenous Immunoglobulin(IVIg) Therapy market based on the following parameters – headquarters, production locations, products portfolio, Intravenous Immunoglobulin(IVIg) Therapy revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Intravenous Immunoglobulin(IVIg) Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Intravenous Immunoglobulin(IVIg) Therapy Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- 1g/20ml
- 1.25g/25ml
- 2.5g/50ml
- 5g/100ml
- 10g/200ml
- Others
- Immunodeficiency
- Autoimmune Disease
- Acute Infection
- Others
- TEIJIN LIMITED
- Grifols
- Biotest
- Kamada
- Takeda
- Octapharma
- Kedrion
- LFB Group
- Baxter
- Nanyue Biopharming
- Boya-Bio
- CSL Plasma
- CNBG
- Beijing Tiantan Biological Products
- Hualan Bio
- Guangdong Shuagnlin Bio-pharmacy
- Weiguang Biological
- Sinopharm
- Shanghai RAAS
- Taibang Biologic Group
1. How big is the global Intravenous Immunoglobulin(IVIg) Therapy market?
2. What is the demand of the global Intravenous Immunoglobulin(IVIg) Therapy market?
3. What is the year over year growth of the global Intravenous Immunoglobulin(IVIg) Therapy market?
4. What is the production and production value of the global Intravenous Immunoglobulin(IVIg) Therapy market?
5. Who are the key producers in the global Intravenous Immunoglobulin(IVIg) Therapy market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Intravenous Immunoglobulin(IVIg) Therapy Introduction
1.2 World Intravenous Immunoglobulin(IVIg) Therapy Supply & Forecast
1.2.1 World Intravenous Immunoglobulin(IVIg) Therapy Production Value (2017 & 2021 & 2028)
1.2.2 World Intravenous Immunoglobulin(IVIg) Therapy Production (2017-2028)
1.2.3 World Intravenous Immunoglobulin(IVIg) Therapy Pricing Trends (2017-2028)
1.3 World Intravenous Immunoglobulin(IVIg) Therapy Production by Region
1.3.1 World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Region (2017-2028)
1.3.2 World Intravenous Immunoglobulin(IVIg) Therapy Production by Region (2017-2028)
1.3.3 World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Region (2017-2028)
1.3.4 North America Intravenous Immunoglobulin(IVIg) Therapy Production (2017-2028)
1.3.5 Europe Intravenous Immunoglobulin(IVIg) Therapy Production (2017-2028)
1.3.6 China Intravenous Immunoglobulin(IVIg) Therapy Production (2017-2028)
1.3.7 Japan Intravenous Immunoglobulin(IVIg) Therapy Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Intravenous Immunoglobulin(IVIg) Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Intravenous Immunoglobulin(IVIg) Therapy Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Intravenous Immunoglobulin(IVIg) Therapy Demand (2017-2028)
2.2 World Intravenous Immunoglobulin(IVIg) Therapy Consumption by Region
2.2.1 World Intravenous Immunoglobulin(IVIg) Therapy Consumption by Region (2017-2022)
2.2.2 World Intravenous Immunoglobulin(IVIg) Therapy Consumption Forecast by Region (2023-2028)
2.3 United States Intravenous Immunoglobulin(IVIg) Therapy Consumption (2017-2028)
2.4 China Intravenous Immunoglobulin(IVIg) Therapy Consumption (2017-2028)
2.5 Europe Intravenous Immunoglobulin(IVIg) Therapy Consumption (2017-2028)
2.6 Japan Intravenous Immunoglobulin(IVIg) Therapy Consumption (2017-2028)
2.7 South Korea Intravenous Immunoglobulin(IVIg) Therapy Consumption (2017-2028)
2.8 ASEAN Intravenous Immunoglobulin(IVIg) Therapy Consumption (2017-2028)
2.9 India Intravenous Immunoglobulin(IVIg) Therapy Consumption (2017-2028)
3 WORLD INTRAVENOUS IMMUNOGLOBULIN(IVIG) THERAPY MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Manufacturer (2017-2022)
3.2 World Intravenous Immunoglobulin(IVIg) Therapy Production by Manufacturer (2017-2022)
3.3 World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Manufacturer (2017-2022)
3.4 Intravenous Immunoglobulin(IVIg) Therapy Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Intravenous Immunoglobulin(IVIg) Therapy Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Intravenous Immunoglobulin(IVIg) Therapy in 2021
3.5.3 Global Concentration Ratios (CR8) for Intravenous Immunoglobulin(IVIg) Therapy in 2021
3.6 Intravenous Immunoglobulin(IVIg) Therapy Market: Overall Company Footprint Analysis
3.6.1 Intravenous Immunoglobulin(IVIg) Therapy Market: Region Footprint
3.6.2 Intravenous Immunoglobulin(IVIg) Therapy Market: Company Product Type Footprint
3.6.3 Intravenous Immunoglobulin(IVIg) Therapy Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Value Comparison
4.1.1 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Comparison
4.2.1 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Consumption Comparison
4.3.1 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Intravenous Immunoglobulin(IVIg) Therapy Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Intravenous Immunoglobulin(IVIg) Therapy in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Intravenous Immunoglobulin(IVIg) Therapy Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Intravenous Immunoglobulin(IVIg) Therapy Production by Domestic Manufacturer, (2017-2022)
4.5 China Intravenous Immunoglobulin(IVIg) Therapy Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Intravenous Immunoglobulin(IVIg) Therapy in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Intravenous Immunoglobulin(IVIg) Therapy Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Intravenous Immunoglobulin(IVIg) Therapy Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Intravenous Immunoglobulin(IVIg) Therapy Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Intravenous Immunoglobulin(IVIg) Therapy in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Intravenous Immunoglobulin(IVIg) Therapy Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Intravenous Immunoglobulin(IVIg) Therapy Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 1g/20ml
5.2.2 1.25g/25ml
5.2.3 2.5g/50ml
5.2.4 5g/100ml
5.2.5 10g/200ml
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World Intravenous Immunoglobulin(IVIg) Therapy Production by Type (2017-2028)
5.3.2 World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Type (2017-2028)
5.3.3 World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Intravenous Immunoglobulin(IVIg) Therapy Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Immunodeficiency
6.2.2 Autoimmune Disease
6.2.3 Acute Infection
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Intravenous Immunoglobulin(IVIg) Therapy Production by Application (2017-2028)
6.3.2 World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Application (2017-2028)
6.3.3 World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 TEIJIN LIMITED
7.1.1 TEIJIN LIMITED Details
7.1.2 TEIJIN LIMITED Major Business
7.1.3 TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.1.4 TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 TEIJIN LIMITED Recent Developments/Updates
7.1.6 TEIJIN LIMITED Competitive Strengths & Weaknesses
7.2 Grifols
7.2.1 Grifols Details
7.2.2 Grifols Major Business
7.2.3 Grifols Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.2.4 Grifols Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Grifols Recent Developments/Updates
7.2.6 Grifols Competitive Strengths & Weaknesses
7.3 Biotest
7.3.1 Biotest Details
7.3.2 Biotest Major Business
7.3.3 Biotest Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.3.4 Biotest Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Biotest Recent Developments/Updates
7.3.6 Biotest Competitive Strengths & Weaknesses
7.4 Kamada
7.4.1 Kamada Details
7.4.2 Kamada Major Business
7.4.3 Kamada Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.4.4 Kamada Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Kamada Recent Developments/Updates
7.4.6 Kamada Competitive Strengths & Weaknesses
7.5 Takeda
7.5.1 Takeda Details
7.5.2 Takeda Major Business
7.5.3 Takeda Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.5.4 Takeda Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Takeda Recent Developments/Updates
7.5.6 Takeda Competitive Strengths & Weaknesses
7.6 Octapharma
7.6.1 Octapharma Details
7.6.2 Octapharma Major Business
7.6.3 Octapharma Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.6.4 Octapharma Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Octapharma Recent Developments/Updates
7.6.6 Octapharma Competitive Strengths & Weaknesses
7.7 Kedrion
7.7.1 Kedrion Details
7.7.2 Kedrion Major Business
7.7.3 Kedrion Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.7.4 Kedrion Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Kedrion Recent Developments/Updates
7.7.6 Kedrion Competitive Strengths & Weaknesses
7.8 LFB Group
7.8.1 LFB Group Details
7.8.2 LFB Group Major Business
7.8.3 LFB Group Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.8.4 LFB Group Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 LFB Group Recent Developments/Updates
7.8.6 LFB Group Competitive Strengths & Weaknesses
7.9 Baxter
7.9.1 Baxter Details
7.9.2 Baxter Major Business
7.9.3 Baxter Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.9.4 Baxter Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Baxter Recent Developments/Updates
7.9.6 Baxter Competitive Strengths & Weaknesses
7.10 Nanyue Biopharming
7.10.1 Nanyue Biopharming Details
7.10.2 Nanyue Biopharming Major Business
7.10.3 Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.10.4 Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Nanyue Biopharming Recent Developments/Updates
7.10.6 Nanyue Biopharming Competitive Strengths & Weaknesses
7.11 Boya-Bio
7.11.1 Boya-Bio Details
7.11.2 Boya-Bio Major Business
7.11.3 Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.11.4 Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Boya-Bio Recent Developments/Updates
7.11.6 Boya-Bio Competitive Strengths & Weaknesses
7.12 CSL Plasma
7.12.1 CSL Plasma Details
7.12.2 CSL Plasma Major Business
7.12.3 CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.12.4 CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 CSL Plasma Recent Developments/Updates
7.12.6 CSL Plasma Competitive Strengths & Weaknesses
7.13 CNBG
7.13.1 CNBG Details
7.13.2 CNBG Major Business
7.13.3 CNBG Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.13.4 CNBG Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 CNBG Recent Developments/Updates
7.13.6 CNBG Competitive Strengths & Weaknesses
7.14 Beijing Tiantan Biological Products
7.14.1 Beijing Tiantan Biological Products Details
7.14.2 Beijing Tiantan Biological Products Major Business
7.14.3 Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.14.4 Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Beijing Tiantan Biological Products Recent Developments/Updates
7.14.6 Beijing Tiantan Biological Products Competitive Strengths & Weaknesses
7.15 Hualan Bio
7.15.1 Hualan Bio Details
7.15.2 Hualan Bio Major Business
7.15.3 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.15.4 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Hualan Bio Recent Developments/Updates
7.15.6 Hualan Bio Competitive Strengths & Weaknesses
7.16 Guangdong Shuagnlin Bio-pharmacy
7.16.1 Guangdong Shuagnlin Bio-pharmacy Details
7.16.2 Guangdong Shuagnlin Bio-pharmacy Major Business
7.16.3 Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.16.4 Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Guangdong Shuagnlin Bio-pharmacy Recent Developments/Updates
7.16.6 Guangdong Shuagnlin Bio-pharmacy Competitive Strengths & Weaknesses
7.17 Weiguang Biological
7.17.1 Weiguang Biological Details
7.17.2 Weiguang Biological Major Business
7.17.3 Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.17.4 Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 Weiguang Biological Recent Developments/Updates
7.17.6 Weiguang Biological Competitive Strengths & Weaknesses
7.18 Sinopharm
7.18.1 Sinopharm Details
7.18.2 Sinopharm Major Business
7.18.3 Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.18.4 Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.18.5 Sinopharm Recent Developments/Updates
7.18.6 Sinopharm Competitive Strengths & Weaknesses
7.19 Shanghai RAAS
7.19.1 Shanghai RAAS Details
7.19.2 Shanghai RAAS Major Business
7.19.3 Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.19.4 Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.19.5 Shanghai RAAS Recent Developments/Updates
7.19.6 Shanghai RAAS Competitive Strengths & Weaknesses
7.20 Taibang Biologic Group
7.20.1 Taibang Biologic Group Details
7.20.2 Taibang Biologic Group Major Business
7.20.3 Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.20.4 Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.20.5 Taibang Biologic Group Recent Developments/Updates
7.20.6 Taibang Biologic Group Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Intravenous Immunoglobulin(IVIg) Therapy and Key Manufacturers
8.2 Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Costs
8.3 Intravenous Immunoglobulin(IVIg) Therapy Production Process
8.4 Intravenous Immunoglobulin(IVIg) Therapy Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Intravenous Immunoglobulin(IVIg) Therapy Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Intravenous Immunoglobulin(IVIg) Therapy Typical Distributors
9.3 Intravenous Immunoglobulin(IVIg) Therapy Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Intravenous Immunoglobulin(IVIg) Therapy Introduction
1.2 World Intravenous Immunoglobulin(IVIg) Therapy Supply & Forecast
1.2.1 World Intravenous Immunoglobulin(IVIg) Therapy Production Value (2017 & 2021 & 2028)
1.2.2 World Intravenous Immunoglobulin(IVIg) Therapy Production (2017-2028)
1.2.3 World Intravenous Immunoglobulin(IVIg) Therapy Pricing Trends (2017-2028)
1.3 World Intravenous Immunoglobulin(IVIg) Therapy Production by Region
1.3.1 World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Region (2017-2028)
1.3.2 World Intravenous Immunoglobulin(IVIg) Therapy Production by Region (2017-2028)
1.3.3 World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Region (2017-2028)
1.3.4 North America Intravenous Immunoglobulin(IVIg) Therapy Production (2017-2028)
1.3.5 Europe Intravenous Immunoglobulin(IVIg) Therapy Production (2017-2028)
1.3.6 China Intravenous Immunoglobulin(IVIg) Therapy Production (2017-2028)
1.3.7 Japan Intravenous Immunoglobulin(IVIg) Therapy Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Intravenous Immunoglobulin(IVIg) Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Intravenous Immunoglobulin(IVIg) Therapy Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Intravenous Immunoglobulin(IVIg) Therapy Demand (2017-2028)
2.2 World Intravenous Immunoglobulin(IVIg) Therapy Consumption by Region
2.2.1 World Intravenous Immunoglobulin(IVIg) Therapy Consumption by Region (2017-2022)
2.2.2 World Intravenous Immunoglobulin(IVIg) Therapy Consumption Forecast by Region (2023-2028)
2.3 United States Intravenous Immunoglobulin(IVIg) Therapy Consumption (2017-2028)
2.4 China Intravenous Immunoglobulin(IVIg) Therapy Consumption (2017-2028)
2.5 Europe Intravenous Immunoglobulin(IVIg) Therapy Consumption (2017-2028)
2.6 Japan Intravenous Immunoglobulin(IVIg) Therapy Consumption (2017-2028)
2.7 South Korea Intravenous Immunoglobulin(IVIg) Therapy Consumption (2017-2028)
2.8 ASEAN Intravenous Immunoglobulin(IVIg) Therapy Consumption (2017-2028)
2.9 India Intravenous Immunoglobulin(IVIg) Therapy Consumption (2017-2028)
3 WORLD INTRAVENOUS IMMUNOGLOBULIN(IVIG) THERAPY MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Manufacturer (2017-2022)
3.2 World Intravenous Immunoglobulin(IVIg) Therapy Production by Manufacturer (2017-2022)
3.3 World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Manufacturer (2017-2022)
3.4 Intravenous Immunoglobulin(IVIg) Therapy Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Intravenous Immunoglobulin(IVIg) Therapy Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Intravenous Immunoglobulin(IVIg) Therapy in 2021
3.5.3 Global Concentration Ratios (CR8) for Intravenous Immunoglobulin(IVIg) Therapy in 2021
3.6 Intravenous Immunoglobulin(IVIg) Therapy Market: Overall Company Footprint Analysis
3.6.1 Intravenous Immunoglobulin(IVIg) Therapy Market: Region Footprint
3.6.2 Intravenous Immunoglobulin(IVIg) Therapy Market: Company Product Type Footprint
3.6.3 Intravenous Immunoglobulin(IVIg) Therapy Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Value Comparison
4.1.1 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Comparison
4.2.1 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Consumption Comparison
4.3.1 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Intravenous Immunoglobulin(IVIg) Therapy Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Intravenous Immunoglobulin(IVIg) Therapy in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Intravenous Immunoglobulin(IVIg) Therapy Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Intravenous Immunoglobulin(IVIg) Therapy Production by Domestic Manufacturer, (2017-2022)
4.5 China Intravenous Immunoglobulin(IVIg) Therapy Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Intravenous Immunoglobulin(IVIg) Therapy in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Intravenous Immunoglobulin(IVIg) Therapy Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Intravenous Immunoglobulin(IVIg) Therapy Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Intravenous Immunoglobulin(IVIg) Therapy Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Intravenous Immunoglobulin(IVIg) Therapy in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Intravenous Immunoglobulin(IVIg) Therapy Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Intravenous Immunoglobulin(IVIg) Therapy Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 1g/20ml
5.2.2 1.25g/25ml
5.2.3 2.5g/50ml
5.2.4 5g/100ml
5.2.5 10g/200ml
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World Intravenous Immunoglobulin(IVIg) Therapy Production by Type (2017-2028)
5.3.2 World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Type (2017-2028)
5.3.3 World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Intravenous Immunoglobulin(IVIg) Therapy Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Immunodeficiency
6.2.2 Autoimmune Disease
6.2.3 Acute Infection
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Intravenous Immunoglobulin(IVIg) Therapy Production by Application (2017-2028)
6.3.2 World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Application (2017-2028)
6.3.3 World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 TEIJIN LIMITED
7.1.1 TEIJIN LIMITED Details
7.1.2 TEIJIN LIMITED Major Business
7.1.3 TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.1.4 TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 TEIJIN LIMITED Recent Developments/Updates
7.1.6 TEIJIN LIMITED Competitive Strengths & Weaknesses
7.2 Grifols
7.2.1 Grifols Details
7.2.2 Grifols Major Business
7.2.3 Grifols Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.2.4 Grifols Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Grifols Recent Developments/Updates
7.2.6 Grifols Competitive Strengths & Weaknesses
7.3 Biotest
7.3.1 Biotest Details
7.3.2 Biotest Major Business
7.3.3 Biotest Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.3.4 Biotest Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Biotest Recent Developments/Updates
7.3.6 Biotest Competitive Strengths & Weaknesses
7.4 Kamada
7.4.1 Kamada Details
7.4.2 Kamada Major Business
7.4.3 Kamada Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.4.4 Kamada Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Kamada Recent Developments/Updates
7.4.6 Kamada Competitive Strengths & Weaknesses
7.5 Takeda
7.5.1 Takeda Details
7.5.2 Takeda Major Business
7.5.3 Takeda Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.5.4 Takeda Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Takeda Recent Developments/Updates
7.5.6 Takeda Competitive Strengths & Weaknesses
7.6 Octapharma
7.6.1 Octapharma Details
7.6.2 Octapharma Major Business
7.6.3 Octapharma Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.6.4 Octapharma Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Octapharma Recent Developments/Updates
7.6.6 Octapharma Competitive Strengths & Weaknesses
7.7 Kedrion
7.7.1 Kedrion Details
7.7.2 Kedrion Major Business
7.7.3 Kedrion Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.7.4 Kedrion Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Kedrion Recent Developments/Updates
7.7.6 Kedrion Competitive Strengths & Weaknesses
7.8 LFB Group
7.8.1 LFB Group Details
7.8.2 LFB Group Major Business
7.8.3 LFB Group Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.8.4 LFB Group Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 LFB Group Recent Developments/Updates
7.8.6 LFB Group Competitive Strengths & Weaknesses
7.9 Baxter
7.9.1 Baxter Details
7.9.2 Baxter Major Business
7.9.3 Baxter Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.9.4 Baxter Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Baxter Recent Developments/Updates
7.9.6 Baxter Competitive Strengths & Weaknesses
7.10 Nanyue Biopharming
7.10.1 Nanyue Biopharming Details
7.10.2 Nanyue Biopharming Major Business
7.10.3 Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.10.4 Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Nanyue Biopharming Recent Developments/Updates
7.10.6 Nanyue Biopharming Competitive Strengths & Weaknesses
7.11 Boya-Bio
7.11.1 Boya-Bio Details
7.11.2 Boya-Bio Major Business
7.11.3 Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.11.4 Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Boya-Bio Recent Developments/Updates
7.11.6 Boya-Bio Competitive Strengths & Weaknesses
7.12 CSL Plasma
7.12.1 CSL Plasma Details
7.12.2 CSL Plasma Major Business
7.12.3 CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.12.4 CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 CSL Plasma Recent Developments/Updates
7.12.6 CSL Plasma Competitive Strengths & Weaknesses
7.13 CNBG
7.13.1 CNBG Details
7.13.2 CNBG Major Business
7.13.3 CNBG Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.13.4 CNBG Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 CNBG Recent Developments/Updates
7.13.6 CNBG Competitive Strengths & Weaknesses
7.14 Beijing Tiantan Biological Products
7.14.1 Beijing Tiantan Biological Products Details
7.14.2 Beijing Tiantan Biological Products Major Business
7.14.3 Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.14.4 Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Beijing Tiantan Biological Products Recent Developments/Updates
7.14.6 Beijing Tiantan Biological Products Competitive Strengths & Weaknesses
7.15 Hualan Bio
7.15.1 Hualan Bio Details
7.15.2 Hualan Bio Major Business
7.15.3 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.15.4 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Hualan Bio Recent Developments/Updates
7.15.6 Hualan Bio Competitive Strengths & Weaknesses
7.16 Guangdong Shuagnlin Bio-pharmacy
7.16.1 Guangdong Shuagnlin Bio-pharmacy Details
7.16.2 Guangdong Shuagnlin Bio-pharmacy Major Business
7.16.3 Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.16.4 Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Guangdong Shuagnlin Bio-pharmacy Recent Developments/Updates
7.16.6 Guangdong Shuagnlin Bio-pharmacy Competitive Strengths & Weaknesses
7.17 Weiguang Biological
7.17.1 Weiguang Biological Details
7.17.2 Weiguang Biological Major Business
7.17.3 Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.17.4 Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 Weiguang Biological Recent Developments/Updates
7.17.6 Weiguang Biological Competitive Strengths & Weaknesses
7.18 Sinopharm
7.18.1 Sinopharm Details
7.18.2 Sinopharm Major Business
7.18.3 Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.18.4 Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.18.5 Sinopharm Recent Developments/Updates
7.18.6 Sinopharm Competitive Strengths & Weaknesses
7.19 Shanghai RAAS
7.19.1 Shanghai RAAS Details
7.19.2 Shanghai RAAS Major Business
7.19.3 Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.19.4 Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.19.5 Shanghai RAAS Recent Developments/Updates
7.19.6 Shanghai RAAS Competitive Strengths & Weaknesses
7.20 Taibang Biologic Group
7.20.1 Taibang Biologic Group Details
7.20.2 Taibang Biologic Group Major Business
7.20.3 Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Product and Services
7.20.4 Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.20.5 Taibang Biologic Group Recent Developments/Updates
7.20.6 Taibang Biologic Group Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Intravenous Immunoglobulin(IVIg) Therapy and Key Manufacturers
8.2 Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Costs
8.3 Intravenous Immunoglobulin(IVIg) Therapy Production Process
8.4 Intravenous Immunoglobulin(IVIg) Therapy Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Intravenous Immunoglobulin(IVIg) Therapy Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Intravenous Immunoglobulin(IVIg) Therapy Typical Distributors
9.3 Intravenous Immunoglobulin(IVIg) Therapy Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Region (2017-2022) & (USD Million)
Table 3. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Region (2023-2028) & (USD Million)
Table 4. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Region (2017-2022)
Table 5. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Region (2023-2028)
Table 6. World Intravenous Immunoglobulin(IVIg) Therapy Production by Region (2017-2022) & (K Units)
Table 7. World Intravenous Immunoglobulin(IVIg) Therapy Production by Region (2023-2028) & (K Units)
Table 8. World Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Region (2017-2022)
Table 9. World Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Region (2023-2028)
Table 10. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Intravenous Immunoglobulin(IVIg) Therapy Major Market Trends
Table 13. World Intravenous Immunoglobulin(IVIg) Therapy Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Intravenous Immunoglobulin(IVIg) Therapy Consumption by Region (2017-2022) & (K Units)
Table 15. World Intravenous Immunoglobulin(IVIg) Therapy Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Intravenous Immunoglobulin(IVIg) Therapy Producers in 2021
Table 18. World Intravenous Immunoglobulin(IVIg) Therapy Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Intravenous Immunoglobulin(IVIg) Therapy Producers in 2021
Table 20. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Intravenous Immunoglobulin(IVIg) Therapy Company Evaluation Quadrant
Table 22. World Intravenous Immunoglobulin(IVIg) Therapy Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Intravenous Immunoglobulin(IVIg) Therapy Production Site of Key Manufacturer
Table 24. Intravenous Immunoglobulin(IVIg) Therapy Market: Company Product Type Footprint
Table 25. Intravenous Immunoglobulin(IVIg) Therapy Market: Company Product Application Footprint
Table 26. Intravenous Immunoglobulin(IVIg) Therapy Competitive Factors
Table 27. Intravenous Immunoglobulin(IVIg) Therapy New Entrant and Capacity Expansion Plans
Table 28. Intravenous Immunoglobulin(IVIg) Therapy Mergers & Acquisitions Activity
Table 29. United States VS China Intravenous Immunoglobulin(IVIg) Therapy Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Intravenous Immunoglobulin(IVIg) Therapy Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Intravenous Immunoglobulin(IVIg) Therapy Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Intravenous Immunoglobulin(IVIg) Therapy in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Intravenous Immunoglobulin(IVIg) Therapy Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Intravenous Immunoglobulin(IVIg) Therapy Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Intravenous Immunoglobulin(IVIg) Therapy in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Intravenous Immunoglobulin(IVIg) Therapy Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Intravenous Immunoglobulin(IVIg) Therapy Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Intravenous Immunoglobulin(IVIg) Therapy in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Intravenous Immunoglobulin(IVIg) Therapy Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Intravenous Immunoglobulin(IVIg) Therapy Production by Type (2017-2022) & (K Units)
Table 49. World Intravenous Immunoglobulin(IVIg) Therapy Production by Type (2023-2028) & (K Units)
Table 50. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Type (2017-2022) & (USD Million)
Table 51. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Type (2023-2028) & (USD Million)
Table 52. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Intravenous Immunoglobulin(IVIg) Therapy Production by Application (2017-2022) & (K Units)
Table 56. World Intravenous Immunoglobulin(IVIg) Therapy Production by Application (2023-2028) & (K Units)
Table 57. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Application (2017-2022) & (USD Million)
Table 58. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Application (2023-2028) & (USD Million)
Table 59. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Application (2023-2028) & (US$/Unit)
Table 61. TEIJIN LIMITED Basic Information, Manufacturing Base and Competitors
Table 62. TEIJIN LIMITED Major Business
Table 63. TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 64. TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. TEIJIN LIMITED Recent Developments/Updates
Table 66. TEIJIN LIMITED Competitive Strengths & Weaknesses
Table 67. Grifols Basic Information, Manufacturing Base and Competitors
Table 68. Grifols Major Business
Table 69. Grifols Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 70. Grifols Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Grifols Recent Developments/Updates
Table 72. Grifols Competitive Strengths & Weaknesses
Table 73. Biotest Basic Information, Manufacturing Base and Competitors
Table 74. Biotest Major Business
Table 75. Biotest Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 76. Biotest Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Biotest Recent Developments/Updates
Table 78. Biotest Competitive Strengths & Weaknesses
Table 79. Kamada Basic Information, Manufacturing Base and Competitors
Table 80. Kamada Major Business
Table 81. Kamada Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 82. Kamada Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Kamada Recent Developments/Updates
Table 84. Kamada Competitive Strengths & Weaknesses
Table 85. Takeda Basic Information, Manufacturing Base and Competitors
Table 86. Takeda Major Business
Table 87. Takeda Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 88. Takeda Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Takeda Recent Developments/Updates
Table 90. Takeda Competitive Strengths & Weaknesses
Table 91. Octapharma Basic Information, Manufacturing Base and Competitors
Table 92. Octapharma Major Business
Table 93. Octapharma Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 94. Octapharma Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Octapharma Recent Developments/Updates
Table 96. Octapharma Competitive Strengths & Weaknesses
Table 97. Kedrion Basic Information, Manufacturing Base and Competitors
Table 98. Kedrion Major Business
Table 99. Kedrion Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 100. Kedrion Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Kedrion Recent Developments/Updates
Table 102. Kedrion Competitive Strengths & Weaknesses
Table 103. LFB Group Basic Information, Manufacturing Base and Competitors
Table 104. LFB Group Major Business
Table 105. LFB Group Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 106. LFB Group Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. LFB Group Recent Developments/Updates
Table 108. LFB Group Competitive Strengths & Weaknesses
Table 109. Baxter Basic Information, Manufacturing Base and Competitors
Table 110. Baxter Major Business
Table 111. Baxter Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 112. Baxter Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Baxter Recent Developments/Updates
Table 114. Baxter Competitive Strengths & Weaknesses
Table 115. Nanyue Biopharming Basic Information, Manufacturing Base and Competitors
Table 116. Nanyue Biopharming Major Business
Table 117. Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 118. Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Nanyue Biopharming Recent Developments/Updates
Table 120. Nanyue Biopharming Competitive Strengths & Weaknesses
Table 121. Boya-Bio Basic Information, Manufacturing Base and Competitors
Table 122. Boya-Bio Major Business
Table 123. Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 124. Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Boya-Bio Recent Developments/Updates
Table 126. Boya-Bio Competitive Strengths & Weaknesses
Table 127. CSL Plasma Basic Information, Manufacturing Base and Competitors
Table 128. CSL Plasma Major Business
Table 129. CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 130. CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. CSL Plasma Recent Developments/Updates
Table 132. CSL Plasma Competitive Strengths & Weaknesses
Table 133. CNBG Basic Information, Manufacturing Base and Competitors
Table 134. CNBG Major Business
Table 135. CNBG Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 136. CNBG Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. CNBG Recent Developments/Updates
Table 138. CNBG Competitive Strengths & Weaknesses
Table 139. Beijing Tiantan Biological Products Basic Information, Manufacturing Base and Competitors
Table 140. Beijing Tiantan Biological Products Major Business
Table 141. Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 142. Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Beijing Tiantan Biological Products Recent Developments/Updates
Table 144. Beijing Tiantan Biological Products Competitive Strengths & Weaknesses
Table 145. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 146. Hualan Bio Major Business
Table 147. Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 148. Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Hualan Bio Recent Developments/Updates
Table 150. Hualan Bio Competitive Strengths & Weaknesses
Table 151. Guangdong Shuagnlin Bio-pharmacy Basic Information, Manufacturing Base and Competitors
Table 152. Guangdong Shuagnlin Bio-pharmacy Major Business
Table 153. Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 154. Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. Guangdong Shuagnlin Bio-pharmacy Recent Developments/Updates
Table 156. Guangdong Shuagnlin Bio-pharmacy Competitive Strengths & Weaknesses
Table 157. Weiguang Biological Basic Information, Manufacturing Base and Competitors
Table 158. Weiguang Biological Major Business
Table 159. Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 160. Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 161. Weiguang Biological Recent Developments/Updates
Table 162. Weiguang Biological Competitive Strengths & Weaknesses
Table 163. Sinopharm Basic Information, Manufacturing Base and Competitors
Table 164. Sinopharm Major Business
Table 165. Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 166. Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 167. Sinopharm Recent Developments/Updates
Table 168. Sinopharm Competitive Strengths & Weaknesses
Table 169. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
Table 170. Shanghai RAAS Major Business
Table 171. Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 172. Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 173. Shanghai RAAS Recent Developments/Updates
Table 174. Taibang Biologic Group Basic Information, Manufacturing Base and Competitors
Table 175. Taibang Biologic Group Major Business
Table 176. Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 177. Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 178. Intravenous Immunoglobulin(IVIg) Therapy Raw Material
Table 179. Key Manufacturers of Intravenous Immunoglobulin(IVIg) Therapy Raw Materials
Table 180. Intravenous Immunoglobulin(IVIg) Therapy Typical Distributors
Table 181. Intravenous Immunoglobulin(IVIg) Therapy Typical Customers
List of Figure
Figure 1. Intravenous Immunoglobulin(IVIg) Therapy Picture
Figure 2. World Intravenous Immunoglobulin(IVIg) Therapy Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Intravenous Immunoglobulin(IVIg) Therapy Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Intravenous Immunoglobulin(IVIg) Therapy Production (2017-2028) & (K Units)
Figure 5. World Intravenous Immunoglobulin(IVIg) Therapy Average Price (2017-2028) & (US$/Unit)
Figure 6. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Region (2017-2028)
Figure 7. World Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Region (2017-2028)
Figure 8. North America Intravenous Immunoglobulin(IVIg) Therapy Production (2017-2028) & (K Units)
Figure 9. Europe Intravenous Immunoglobulin(IVIg) Therapy Production (2017-2028) & (K Units)
Figure 10. China Intravenous Immunoglobulin(IVIg) Therapy Production (2017-2028) & (K Units)
Figure 11. Japan Intravenous Immunoglobulin(IVIg) Therapy Production (2017-2028) & (K Units)
Figure 12. Intravenous Immunoglobulin(IVIg) Therapy Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Intravenous Immunoglobulin(IVIg) Therapy Demand (2017-2028) & (K Units)
Figure 15. World Intravenous Immunoglobulin(IVIg) Therapy Consumption Market Share by Region (2017-2028)
Figure 16. United States Intravenous Immunoglobulin(IVIg) Therapy Consumption (2017-2028) & (K Units)
Figure 17. China Intravenous Immunoglobulin(IVIg) Therapy Consumption (2017-2028) & (K Units)
Figure 18. Europe Intravenous Immunoglobulin(IVIg) Therapy Consumption (2017-2028) & (K Units)
Figure 19. Japan Intravenous Immunoglobulin(IVIg) Therapy Consumption (2017-2028) & (K Units)
Figure 20. South Korea Intravenous Immunoglobulin(IVIg) Therapy Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Intravenous Immunoglobulin(IVIg) Therapy Consumption (2017-2028) & (K Units)
Figure 22. India Intravenous Immunoglobulin(IVIg) Therapy Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Intravenous Immunoglobulin(IVIg) Therapy by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Intravenous Immunoglobulin(IVIg) Therapy Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Intravenous Immunoglobulin(IVIg) Therapy Markets in 2021
Figure 26. United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Intravenous Immunoglobulin(IVIg) Therapy in United States
Figure 30. Key Producers and Market Share of Intravenous Immunoglobulin(IVIg) Therapy in China
Figure 31. Key Producers and Market Share of Intravenous Immunoglobulin(IVIg) Therapy in Rest of World
Figure 32. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Type in 2021
Figure 34. 1g/20ml
Figure 35. 1.25g/25ml
Figure 36. 2.5g/50ml
Figure 37. 5g/100ml
Figure 38. 10g/200ml
Figure 39. Others
Figure 40. World Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Type (2017-2028)
Figure 41. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Type (2017-2028)
Figure 42. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Type (2017-2028) & (US$/Unit)
Figure 43. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 44. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Application in 2021
Figure 45. Immunodeficiency
Figure 46. Autoimmune Disease
Figure 47. Acute Infection
Figure 48. Others
Figure 49. World Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Application (2017-2028)
Figure 50. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Application (2017-2028)
Figure 51. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Application (2017-2028) & (US$/Unit)
Figure 52. Manufacturing Cost Structure Analysis of Intravenous Immunoglobulin(IVIg) Therapy in 2021
Figure 53. Manufacturing Process Analysis of Intravenous Immunoglobulin(IVIg) Therapy
Figure 54. Intravenous Immunoglobulin(IVIg) Therapy Industrial Chain
Figure 55. Distribution Channel Breakdown for Intravenous Immunoglobulin(IVIg) Therapy Shipments (%): 2017-2028
Figure 56. Direct Channel Pros & Cons
Figure 57. Indirect Channel Pros & Cons
Figure 58. Methodology
Figure 59. Research Process and Data Source
Table 1. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Region (2017-2022) & (USD Million)
Table 3. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Region (2023-2028) & (USD Million)
Table 4. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Region (2017-2022)
Table 5. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Region (2023-2028)
Table 6. World Intravenous Immunoglobulin(IVIg) Therapy Production by Region (2017-2022) & (K Units)
Table 7. World Intravenous Immunoglobulin(IVIg) Therapy Production by Region (2023-2028) & (K Units)
Table 8. World Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Region (2017-2022)
Table 9. World Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Region (2023-2028)
Table 10. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Intravenous Immunoglobulin(IVIg) Therapy Major Market Trends
Table 13. World Intravenous Immunoglobulin(IVIg) Therapy Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Intravenous Immunoglobulin(IVIg) Therapy Consumption by Region (2017-2022) & (K Units)
Table 15. World Intravenous Immunoglobulin(IVIg) Therapy Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Intravenous Immunoglobulin(IVIg) Therapy Producers in 2021
Table 18. World Intravenous Immunoglobulin(IVIg) Therapy Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Intravenous Immunoglobulin(IVIg) Therapy Producers in 2021
Table 20. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Intravenous Immunoglobulin(IVIg) Therapy Company Evaluation Quadrant
Table 22. World Intravenous Immunoglobulin(IVIg) Therapy Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Intravenous Immunoglobulin(IVIg) Therapy Production Site of Key Manufacturer
Table 24. Intravenous Immunoglobulin(IVIg) Therapy Market: Company Product Type Footprint
Table 25. Intravenous Immunoglobulin(IVIg) Therapy Market: Company Product Application Footprint
Table 26. Intravenous Immunoglobulin(IVIg) Therapy Competitive Factors
Table 27. Intravenous Immunoglobulin(IVIg) Therapy New Entrant and Capacity Expansion Plans
Table 28. Intravenous Immunoglobulin(IVIg) Therapy Mergers & Acquisitions Activity
Table 29. United States VS China Intravenous Immunoglobulin(IVIg) Therapy Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Intravenous Immunoglobulin(IVIg) Therapy Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Intravenous Immunoglobulin(IVIg) Therapy Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Intravenous Immunoglobulin(IVIg) Therapy in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Intravenous Immunoglobulin(IVIg) Therapy Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Intravenous Immunoglobulin(IVIg) Therapy Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Intravenous Immunoglobulin(IVIg) Therapy in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Intravenous Immunoglobulin(IVIg) Therapy Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Intravenous Immunoglobulin(IVIg) Therapy Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Intravenous Immunoglobulin(IVIg) Therapy in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Intravenous Immunoglobulin(IVIg) Therapy Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Intravenous Immunoglobulin(IVIg) Therapy Production by Type (2017-2022) & (K Units)
Table 49. World Intravenous Immunoglobulin(IVIg) Therapy Production by Type (2023-2028) & (K Units)
Table 50. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Type (2017-2022) & (USD Million)
Table 51. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Type (2023-2028) & (USD Million)
Table 52. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Intravenous Immunoglobulin(IVIg) Therapy Production by Application (2017-2022) & (K Units)
Table 56. World Intravenous Immunoglobulin(IVIg) Therapy Production by Application (2023-2028) & (K Units)
Table 57. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Application (2017-2022) & (USD Million)
Table 58. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Application (2023-2028) & (USD Million)
Table 59. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Application (2023-2028) & (US$/Unit)
Table 61. TEIJIN LIMITED Basic Information, Manufacturing Base and Competitors
Table 62. TEIJIN LIMITED Major Business
Table 63. TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 64. TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. TEIJIN LIMITED Recent Developments/Updates
Table 66. TEIJIN LIMITED Competitive Strengths & Weaknesses
Table 67. Grifols Basic Information, Manufacturing Base and Competitors
Table 68. Grifols Major Business
Table 69. Grifols Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 70. Grifols Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Grifols Recent Developments/Updates
Table 72. Grifols Competitive Strengths & Weaknesses
Table 73. Biotest Basic Information, Manufacturing Base and Competitors
Table 74. Biotest Major Business
Table 75. Biotest Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 76. Biotest Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Biotest Recent Developments/Updates
Table 78. Biotest Competitive Strengths & Weaknesses
Table 79. Kamada Basic Information, Manufacturing Base and Competitors
Table 80. Kamada Major Business
Table 81. Kamada Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 82. Kamada Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Kamada Recent Developments/Updates
Table 84. Kamada Competitive Strengths & Weaknesses
Table 85. Takeda Basic Information, Manufacturing Base and Competitors
Table 86. Takeda Major Business
Table 87. Takeda Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 88. Takeda Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Takeda Recent Developments/Updates
Table 90. Takeda Competitive Strengths & Weaknesses
Table 91. Octapharma Basic Information, Manufacturing Base and Competitors
Table 92. Octapharma Major Business
Table 93. Octapharma Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 94. Octapharma Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Octapharma Recent Developments/Updates
Table 96. Octapharma Competitive Strengths & Weaknesses
Table 97. Kedrion Basic Information, Manufacturing Base and Competitors
Table 98. Kedrion Major Business
Table 99. Kedrion Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 100. Kedrion Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Kedrion Recent Developments/Updates
Table 102. Kedrion Competitive Strengths & Weaknesses
Table 103. LFB Group Basic Information, Manufacturing Base and Competitors
Table 104. LFB Group Major Business
Table 105. LFB Group Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 106. LFB Group Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. LFB Group Recent Developments/Updates
Table 108. LFB Group Competitive Strengths & Weaknesses
Table 109. Baxter Basic Information, Manufacturing Base and Competitors
Table 110. Baxter Major Business
Table 111. Baxter Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 112. Baxter Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Baxter Recent Developments/Updates
Table 114. Baxter Competitive Strengths & Weaknesses
Table 115. Nanyue Biopharming Basic Information, Manufacturing Base and Competitors
Table 116. Nanyue Biopharming Major Business
Table 117. Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 118. Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Nanyue Biopharming Recent Developments/Updates
Table 120. Nanyue Biopharming Competitive Strengths & Weaknesses
Table 121. Boya-Bio Basic Information, Manufacturing Base and Competitors
Table 122. Boya-Bio Major Business
Table 123. Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 124. Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Boya-Bio Recent Developments/Updates
Table 126. Boya-Bio Competitive Strengths & Weaknesses
Table 127. CSL Plasma Basic Information, Manufacturing Base and Competitors
Table 128. CSL Plasma Major Business
Table 129. CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 130. CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. CSL Plasma Recent Developments/Updates
Table 132. CSL Plasma Competitive Strengths & Weaknesses
Table 133. CNBG Basic Information, Manufacturing Base and Competitors
Table 134. CNBG Major Business
Table 135. CNBG Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 136. CNBG Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. CNBG Recent Developments/Updates
Table 138. CNBG Competitive Strengths & Weaknesses
Table 139. Beijing Tiantan Biological Products Basic Information, Manufacturing Base and Competitors
Table 140. Beijing Tiantan Biological Products Major Business
Table 141. Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 142. Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Beijing Tiantan Biological Products Recent Developments/Updates
Table 144. Beijing Tiantan Biological Products Competitive Strengths & Weaknesses
Table 145. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 146. Hualan Bio Major Business
Table 147. Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 148. Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Hualan Bio Recent Developments/Updates
Table 150. Hualan Bio Competitive Strengths & Weaknesses
Table 151. Guangdong Shuagnlin Bio-pharmacy Basic Information, Manufacturing Base and Competitors
Table 152. Guangdong Shuagnlin Bio-pharmacy Major Business
Table 153. Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 154. Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. Guangdong Shuagnlin Bio-pharmacy Recent Developments/Updates
Table 156. Guangdong Shuagnlin Bio-pharmacy Competitive Strengths & Weaknesses
Table 157. Weiguang Biological Basic Information, Manufacturing Base and Competitors
Table 158. Weiguang Biological Major Business
Table 159. Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 160. Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 161. Weiguang Biological Recent Developments/Updates
Table 162. Weiguang Biological Competitive Strengths & Weaknesses
Table 163. Sinopharm Basic Information, Manufacturing Base and Competitors
Table 164. Sinopharm Major Business
Table 165. Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 166. Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 167. Sinopharm Recent Developments/Updates
Table 168. Sinopharm Competitive Strengths & Weaknesses
Table 169. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
Table 170. Shanghai RAAS Major Business
Table 171. Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 172. Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 173. Shanghai RAAS Recent Developments/Updates
Table 174. Taibang Biologic Group Basic Information, Manufacturing Base and Competitors
Table 175. Taibang Biologic Group Major Business
Table 176. Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Product and Services
Table 177. Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 178. Intravenous Immunoglobulin(IVIg) Therapy Raw Material
Table 179. Key Manufacturers of Intravenous Immunoglobulin(IVIg) Therapy Raw Materials
Table 180. Intravenous Immunoglobulin(IVIg) Therapy Typical Distributors
Table 181. Intravenous Immunoglobulin(IVIg) Therapy Typical Customers
List of Figure
Figure 1. Intravenous Immunoglobulin(IVIg) Therapy Picture
Figure 2. World Intravenous Immunoglobulin(IVIg) Therapy Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Intravenous Immunoglobulin(IVIg) Therapy Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Intravenous Immunoglobulin(IVIg) Therapy Production (2017-2028) & (K Units)
Figure 5. World Intravenous Immunoglobulin(IVIg) Therapy Average Price (2017-2028) & (US$/Unit)
Figure 6. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Region (2017-2028)
Figure 7. World Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Region (2017-2028)
Figure 8. North America Intravenous Immunoglobulin(IVIg) Therapy Production (2017-2028) & (K Units)
Figure 9. Europe Intravenous Immunoglobulin(IVIg) Therapy Production (2017-2028) & (K Units)
Figure 10. China Intravenous Immunoglobulin(IVIg) Therapy Production (2017-2028) & (K Units)
Figure 11. Japan Intravenous Immunoglobulin(IVIg) Therapy Production (2017-2028) & (K Units)
Figure 12. Intravenous Immunoglobulin(IVIg) Therapy Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Intravenous Immunoglobulin(IVIg) Therapy Demand (2017-2028) & (K Units)
Figure 15. World Intravenous Immunoglobulin(IVIg) Therapy Consumption Market Share by Region (2017-2028)
Figure 16. United States Intravenous Immunoglobulin(IVIg) Therapy Consumption (2017-2028) & (K Units)
Figure 17. China Intravenous Immunoglobulin(IVIg) Therapy Consumption (2017-2028) & (K Units)
Figure 18. Europe Intravenous Immunoglobulin(IVIg) Therapy Consumption (2017-2028) & (K Units)
Figure 19. Japan Intravenous Immunoglobulin(IVIg) Therapy Consumption (2017-2028) & (K Units)
Figure 20. South Korea Intravenous Immunoglobulin(IVIg) Therapy Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Intravenous Immunoglobulin(IVIg) Therapy Consumption (2017-2028) & (K Units)
Figure 22. India Intravenous Immunoglobulin(IVIg) Therapy Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Intravenous Immunoglobulin(IVIg) Therapy by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Intravenous Immunoglobulin(IVIg) Therapy Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Intravenous Immunoglobulin(IVIg) Therapy Markets in 2021
Figure 26. United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Intravenous Immunoglobulin(IVIg) Therapy Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Intravenous Immunoglobulin(IVIg) Therapy in United States
Figure 30. Key Producers and Market Share of Intravenous Immunoglobulin(IVIg) Therapy in China
Figure 31. Key Producers and Market Share of Intravenous Immunoglobulin(IVIg) Therapy in Rest of World
Figure 32. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Type in 2021
Figure 34. 1g/20ml
Figure 35. 1.25g/25ml
Figure 36. 2.5g/50ml
Figure 37. 5g/100ml
Figure 38. 10g/200ml
Figure 39. Others
Figure 40. World Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Type (2017-2028)
Figure 41. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Type (2017-2028)
Figure 42. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Type (2017-2028) & (US$/Unit)
Figure 43. World Intravenous Immunoglobulin(IVIg) Therapy Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 44. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Application in 2021
Figure 45. Immunodeficiency
Figure 46. Autoimmune Disease
Figure 47. Acute Infection
Figure 48. Others
Figure 49. World Intravenous Immunoglobulin(IVIg) Therapy Production Market Share by Application (2017-2028)
Figure 50. World Intravenous Immunoglobulin(IVIg) Therapy Production Value Market Share by Application (2017-2028)
Figure 51. World Intravenous Immunoglobulin(IVIg) Therapy Average Price by Application (2017-2028) & (US$/Unit)
Figure 52. Manufacturing Cost Structure Analysis of Intravenous Immunoglobulin(IVIg) Therapy in 2021
Figure 53. Manufacturing Process Analysis of Intravenous Immunoglobulin(IVIg) Therapy
Figure 54. Intravenous Immunoglobulin(IVIg) Therapy Industrial Chain
Figure 55. Distribution Channel Breakdown for Intravenous Immunoglobulin(IVIg) Therapy Shipments (%): 2017-2028
Figure 56. Direct Channel Pros & Cons
Figure 57. Indirect Channel Pros & Cons
Figure 58. Methodology
Figure 59. Research Process and Data Source
